News

May 7th, 2018

Pioneering New 3D Cancer Model to Speed New Treatments

View on UVA Health Newsroom
May 4th, 2018

Q&A with Brian Wamhoff, PhD, Head of Innovation, HemoShear Therapeutics

View on Rare Disease Report
April 20th, 2018

UVA biomedical engineering student gains real work experience at HemoShear

View on UVA Today
March 8th, 2018

HemoShear’s Maple Syrup Urine Disease Model Presented at Society for Inherited Metabolic Disorders Meeting

View on Rare Disease Report
March 8th, 2018

HemoShear Therapeutics And Children’s National Rare Disease Institute To Present Data On Four Research Programs In Children’s Rare Diseases At The Society For Inherited Metabolic Disorders Meeting

Read More »
February 21st, 2018

Shear Insights: New York Academy of Science Features HemoShear Platform for Liver Diseases

Read More »
October 17th, 2017

Takeda and HemoShear Therapeutics Enter Into Exclusive Drug Discovery Partnership in Liver Diseases

Read More »
February 9th, 2017

HemoShear Therapeutics Receives Governor McAuliffe’s 2017 Virginia Science Innovation Award

View on Virginia.gov
January 11th, 2017

Biopharmas Welcome Research Grant-Funding Renewal

View on Bloomberg BNA
January 5th, 2017

HemoShear Therapeutics Appoints John E. Reardon As Head Of Research And Development

Read More »
December 20th, 2016

HemoShear Therapeutics Publishes Data In Journal Of Clinical Investigation Insight On Its Model Of Non-Alcoholic Steatohepatitis (NASH)

Read More »
November 9th, 2016

HemoShear Therapeutics To Present Data From Its Drug Discovery Platform For NASH At The American Association For The Study Of Liver Diseases Annual Meeting

Read More »
View More +

Contact

info@hemoshear.com

501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902